|
(11) | EP 0 202 084 A3 |
(12) | EUROPEAN PATENT APPLICATION |
|
|
|
|||||||||||||||
(54) | Fluoroalkane derivatives |
(57) The invention describes the novel compound 4(Z)-6-([2,4,5-cis]-4-o-hydroxyphenyl-2-trifluoromethyl-1,3-dioxan-5-yl)
hexenoic acid of formula I and its pharmaceutically acceptable salts and pharmaceutical
compositions, which are of value in treating certain pulmonary and/or vascular disorders.
Also described are various processes for the manufacture of the novel compound and
intermediates for use therein. |